The National Research Foundation was established as an independant government agency, through the National Research Foundation Act [Act No.23 of 1998].
The NRF receives its mandate from the National Research Foundation Act (Act No 23 of 1998, as amended). According to Section 3 of the Act, the object of the NRF is to contribute to national development by:
Chief Executive Officer (CEO)
Deputy Chief Executive Officer: National Research Infrastructure Platforms.
Group Executive: Finance and Business Systems and (CFO)
Group Executive: Human Resources and Legal Services
Deputy CEO: Research and Innovation Support and Advancement (RISA)
Announcement: Trans-Atlantic Platform (T-AP) call on Democracy, Governance and Trust (DGT)
Global Knowledge Partnerships Programme Implementation Framework for the 2024 Academic Year
DSI-NRF Postgraduate Student Funding for the 2024 Academic Year
Invitation for Nominations for Professional Development Programme (PDP) Postdoctoral Fellowships for 2023
2023 iThemba Labs Physics Summer School Call for Applications
Bi-annual Progress Reports: Postgraduate Scholarships 2022 – Mid-Year Reports
Announcement of Successful Applications for General Honours Scholarships 2023_July
Announcement of Successful Applications for the 2023 NRF Scarce Skills Post-Doctoral Fellowship
Take Charge of your Future: Apply for a Pan-African University Scholarship today!
Call for Proposals: Japan Science and Technology Agency / Japan International Cooperation Agency Science and Technology Research Partnership for Sustainable Development
Africa’s leading research facility for accelerator based science. Probing fundamental structure and the origins of matter; Advancing the understanding of condensed matter; Impacting the Societal need through provision for the health and environmental sector
The iThemba Laboratory for Accelerator Based Sciences is the continents' biggest facility for particle and nuclear research.
The SAAO is a national facility of the NRF and the national centre for optical and infrared astronomy in South Africa.
SAEON is a national platform for detecting, translating and predicting environmental change.
SAIAB provides unique skills and infrastructure support in marine, estuarine and freshwater ecosystems research, molecular research, collections and bioinformatics.
SARAO is a national facility of the NRF and incorporates radio astronomy instruments and programmes such as MeerKAT and KAT-7 telescopes in the Karoo, (HartRAO) in Gauteng...
South Africa’s innovation revolution must assist in solving our society’s deep and pressing socio-economic challenges. Global competitiveness, shrinking resource availability, and the requirements of a skilled labour force mean that, increasingly, an awareness and understanding of why science and research are critical to our lives is essential for developing an innovation culture.
Within the next five years, the aim is to begin to more fully embed engagement in and with science in the core NRF missions of supporting and promoting new knowledge and growing new knowledge workers. This is led by the formulation of an acceptable NRF position on engaged research which will guide the NRF approach…
NRF | SAASTA is the NRF business division tasked with leading and coordinating the science engagement programme across the NRF and beyond. The NRF is equally committed to ensuring that the science engagement leadership and national coordination role…
The NRF provides leading-edge research infrastructure platforms that ensure that the national research enterprise has the requisite infrastructure to undertake globally competitive discovery science, train the next generation of researchers, support engagement with science by and with the public and promote innovation that positively impacts society, the environment, the economy.
The annual NRF Awards recognize and celebrate South African research excellence. The awards presented to researchers are in two categories, the ratings linked awards and special recognition awards.
The National Research Foundation (NRF) conducts its procurement of goods, services, and works in accordance with its Supply Chain Management Policy in a manner that is fair, equitable, transparent, competitive, and cost-effective
The National Research Foundation (NRF) is guided by its Supply Chain Management Policy in its procurement of goods and services. The Policy sets out the prescripts issued by National Treasury with the exact note referenced in the footnotes. The Supply Chain Management policy adheres to the National Treasury’s prescribed supply chain system framework.
The NRF’s Supply Chain Management Policy and the conduct of supply chain management at the NRF seeks to give effect to section 217 of the South African Constitution which requires that all procurement of goods and services must be done in a manner that is fair, equitable, transparent, competitive and cost-effective.
The National Research Foundation bid awards and contracts. Below is the latest award.
Parkinson’s diseases (PD) is a neurodegenerative disorder which affects millions of people worldwide. With the number of cases estimated to increase by 2040, alternative treatment approaches are necessary as current therapeutics available for PD focus on palliative treatment.
Research funded by the NRF, and conducted by researchers from the University of KwaZulu Natal, reviewed the potential of nanomedicine, particularly lipid nanoparticles, as a promising therapeutic carrier that can be used to deliver drugs for treating PD.
A significant obstacle in treating PD is the protective nature of the blood-brain barrier and its ability to limit access to foreign molecules, including therapeutics. This has resulted in drugs currently used being nonspecific and administered at dosages that result in numerous adverse side-effects.
The study highlights that lipid nanoparticles possess various advantages, including enhanced permeability to the brain through passive diffusion and specific and non-specific transporters. Furthermore, lipid nanoparticle-based vaccines have been found to be reasonably safe, efficient, bioavailable, non-toxic, possess the ability to be conjugated to drugs, as well as be produced on a larger scale for commercial use.
According to the researchers, new avenues have been opened up to advance the use of lipid nanoparticle formulations for treating many disorders, including neurological disorders such as PD. However, more basic research which focuses on lipid nanoparticle novel formulations directed to the brain is needed to promote the optimisation of lipid nanoparticle-based formulations for efficient brain targeting, which can be translated eventually to clinical settings.
Access the full paper published in the International Journal of Molecular Sciences here.
Hit enter to search or ESC to close